Immune Diseases 3 Flashcards
Autograft
self to self, such as a skin graft
Isograft
syngeneic, between identical twins
Allogrant
between genetically different individuals of the same species
Xenograft
Between two species (pig/porcine heart valve to human)
What is the major barrier to transplant success?
Rejection - immune system recognizes the graft as being foreign and attacks it.
What type of grafts are more likely to be compatible?
ABO and HLA compatible grafts
Cellular rejection
T cell mediated graft rejection that involves destruction of donated graft cells by recipient CD8+ cytotoxic T lymphocytes and delayed hypersensitivity reactions triggered by activated recipient CD4+ T hypersensitivies
The major antigenic differences between the donor and recipient that results in rejection of transplants are differences in ________
HLA alleles (highly pleomorphic)
Direct antigenic recognition pathway
donor class I and II MHC antigens on APCS in the graft are recognized by the host CD8+ cytotoxic T cells and CD4+ helper T cells CD4 - proliferate and produce cytokines which induce tissue damage by local delayed hypersensitivity CD8 - differentiate to CTLs that kill graft cells
Indirect antigenic recognition pathway
graft antigens are picked up, processed and displayed by host APCs and activate CD4+ T cells, which damage the graft by a local delayed hypersensitivity reaction and stimulate B lymphocytes to produce abs.
humoral rejection
antibodies produced against alloantigens in the graft mediate rejection
Important preformed anti-donor antibodies
anti-ABO blood groups (naturally formed)
anti-HLA antibodies (pregnancy, previous transfusion)
Hyperacute rejection is possible if…
preformed antibodies are present
The key immunologic factors affecting graft survival are (3)
ABO compatibility
matching HLA loci
absence of preformed anti-HLA antibodies
Hyperacute rejection
result of ABO incompatibility or preformed anti-HLA antibodies in the recipient, which bind to endothelial antigens, activate complement and result in vessel thrombi and ischemic necrosis (TYPE II HYPERSENS)
Onset of hyperacute rejection?
Minutes to hours after surgery
Very acute
Acute rejection
T cell mediated hypersensitivity reactions (host CD4+ T cells release cytokines, activating macrophages, CD8+ T cells)
or from antibody-mediated hypersensitivity reactions (host CD4 cytokines promote proliferation of B cells into plasma that produce anti-HLA abs to endothelial antigens)
Onset of acute rejection?
days to weeks
Chronic rejection
occurs over months or years and is often secondary to vascular injury, as a result of both cell-mediated and antibody-mediated hypersensitivity reactions.
Which type of rejection is the most common cause of renal graft failure?
Chronic
Current immunosuppression regimens usually control..
acute rejections
Two major complications of immunosuppression therapy in a transplant setting
- Increased susceptibility for opportunistic infection
2. Increased risk of malignancies
Opportunistic infections and transplant
CMV, pneumocystis and common community acquired infectious disease.
Malignancy and transplant
EBV and post transplant lymphoproliferative disorders (PTLD), squamous cell carcinoma of skin and Kaposi sarcoma.
Hematopoietic cell transplantation (HCT)
the administration of hematopoietic progenitor cells from any source (blood, marrow, peripheral blood, umbilical cord blood) to reconstitute the bone marrow.
Autologous HCT (auto-HCT)
uses hematopoietic progenitor cells derived from the individual with the disorder
Allogenic HCT (allo-HCT)
uses hematopoietic progenitor cells collected from someone other than the individual with the disorder
Graft vs. Host Disease (GVHD)
Donor t cells recognize the recipients HLA antigens as foreign and react against them. Because host is immunocompromised the host in incapable of mounting a reaction against the grafted lymphocytes, thus allowing the graft lymphocytes to attack the host.
what happens when the T cells from the donor (graft) recognzie the recipient (host) cells as foreign?
GVHD
How do you minimize the complication of GVHD in allogeneic HCT
Transplants are done between donor and recipients that are HLA matched.
Do patients who undergo auto-HCT get GVHD
No!
Where else can GVHD be seen?
Liver transplants (lots of donor T-lymphocytes in liver) or transfusions of blood or platelets (why irradiate blood before transfusion)